Skip to main content
SpringerLink
Log in

Points of action in the campaign against blindness in developing countries

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

This article provides a survey of the problems of prevention of blindness in developing countries. The World Health Organization estimates that 31 million people are blind and 15 million people partially-sighted. The main cause of blindness is cataract. Other causes are trachoma, glaucoma, xerophthalmia, river blindness, corneal scars and leprosy. Prevention or treatment of these causes is possible in more than 80% of cases. The number of blind persons, however, is still increasing due to the increase in population and the immense shortage of all kinds of ophthalmological equipment and personnel. An effective strategy for the prevention of blindness in developing countries should focus on: more cheap cataract operations, increasing teaching facilities for ophthalmic personnel, integration of ophthalmic care into the general health system and the promotion of blindness prevention in political organizations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. International Agency for the Prevention of Blindness (under the direction of Sir John Wilson). World blindness and its prevention Oxford: University Press, 1980.

    Google Scholar 

  2. International Agency for the Prevention of Blindness (under the direction of Sir John Wilson). World blindness and its prevention, vol. 2. Oxford: University Press, 1984.

    Google Scholar 

  3. International Agency for the Prevention of Blindness (under the direction Sir John Wilson). World blindness and its prevention, Vol. 3 Oxford: University Press, 1989.

    Google Scholar 

  4. Foster A, Johnson GJ. Magnitude and causes of blindness in the developing world. Int Ophthalmol 1990; 14: 135–140.

    Google Scholar 

  5. Thylefors B. A simplified methodology for the assessment of blindness and its main causes. World Health Stat Q 1987; 40(2): 129–41.

    Google Scholar 

  6. WHO. WHO Collaborating Center for the Prevention of Blindness and Trachoma. Methods of assessment of avoidable blindness. WHO offset publication; no. 54 Geneva, WHO 1980: 1–42.

    Google Scholar 

  7. WHO. Strategies for the prevention of blindness in national programmes: a primary health care approach. Geneva: WHO 1984: 1–88.

    Google Scholar 

  8. WHO. Available data on blindness (Update 1987). WHO, Geneva, unpublished document WHO/PBL/87.14.

    Google Scholar 

  9. Brilliant GE. The epidemiology of blindness in Nepal, Chelsa. M.I. The Seva Foundation 1988; 176.

    Google Scholar 

  10. Foster A. World blindness: A challenge to all doctors [editorial]. Tropical Doctor 1987; 17(4): 45–6.

    Google Scholar 

  11. Foster A. Childhood blindness. Eye 1988; 2 Supp: 527–36.

    Google Scholar 

  12. Foster A. World distribution of blindness. Community Eye Health 1988; 1: 2–3.

    Google Scholar 

  13. Nwoke BE. The socio-economic aspects of human onchocerciasis in Africa: present appraisal. J Hyg Epidemiol Microbiol Immunol 1990; 34(1): 37–44.

    Google Scholar 

  14. Whitefield R Jr. Dealing with cataract blindness, Part III. Cataract Surgery in Africa. Ophthalmic Surgery 1987; 18, 765–7.

    Google Scholar 

  15. Foster A. Cataract blindness in Africa. Ophthalmic Surgery 1987; 18(5): 384–8.

    Google Scholar 

  16. Wilson Sir John. Clearing the cataract backlog. Br J Ophthalmol 1987; 71: 158–160.

    Google Scholar 

  17. Schwab L. Cataract blindness in developing nations. Int Ophthalmol Clin 1990; 30(1): 16–8.

    Google Scholar 

  18. Roper-Hall MJ. Cataract: A world problem [editorial]. Ophthalmic Surgery 1988; 19(6): 393–4.

    Google Scholar 

  19. Taylor HR. The environment and the lens. Br J Ophthalmol 1980; 64: 303–310.

    Google Scholar 

  20. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract. N Engl J Med 1988; 319: 1429–1433.

    Google Scholar 

  21. Hollows F, Moran D. Cataract: the ultraviolet risk factor. Lancet 1981; ii: 1249–1250.

    Google Scholar 

  22. Chatterjee A. Cataract in Punjab. In: The human lens in relation to cataract. CiBA foundation symposium Series 1973; 19: 265–279.

    Google Scholar 

  23. Minassian DC. Epidemilogical methods in prevention of blindness. Eye 1988; 2 Suppl: 3–12.

    Google Scholar 

  24. Negrel AD, Massembo Yako B, Botaka E, et al. Prevalence et la orignine de la cecite dans le Congo. Bull WHO 1990; 68(27): 237–43.

    Google Scholar 

  25. Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control. Geneva: WHO 1981.

    Google Scholar 

  26. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull WHO 1987; 65: 477–83.

    Google Scholar 

  27. Sole G de, Martel E. Test of the prevention of blindness health education programme for Ethiopean primary schools. Int Ophthalmol 1988; 11: 255–259.

    Google Scholar 

  28. Verrey JD, Foster A, Wormald R, et al. Chronic glaucoma in Northern Ghana: A retrospective study of 397 patients (Bawku Hospital). Eye 1990; 4: 115–120.

    Google Scholar 

  29. Doesschate J ten. Causes of blindness in and around Surabaja, East Java, Indonesia. Jakarta (Indonesia), 1968. Thesis.

  30. Sauter JJM. Xerophthalmia and measles in Kenya. Groningen (The Netherlands), 1976. Thesis.

  31. Dekkers NWHM. The cornea in measles. Rotterdam (The Netherlands) 1981. Thesis.

  32. Pepping F. Xerophthalmia and post-measles eye lesions in children in Tanzania. Wageningen (The Netherlands), 1987. Thesis.

  33. Agtmall EJ van. Vitamin A and proteins in tear fluid. Amsterdam (The Netherlands), 1989. Thesis.

  34. Bloem MW. Vitamin A deficiency, anemia and infections diseases in Northeast Thailand. Maastricht (The Netherlands), 1989. Thesis.

  35. Sommer A, Tarwotjo I, Hussaini G. Incidence, prevalence and scale of blinding malnutrition. Lancet 1981; i: 1407–8.

    Google Scholar 

  36. Sommer A. Nutritional blindness: Xerophthalmia and keratomalacia. New York Oxford: University Press, 1982.

    Google Scholar 

  37. Sommer A. Field guide to the detection and control of Xerophthalmia, 2nd ed. Geneva: WHO 1982.

    Google Scholar 

  38. Sommer A, Emran N, Tjakrasudjatma S. Clinical characteristics of vitamin A responsive and nonresponsive Bitot's spots. Am J Ophthalmol 1980; 190: 160–71.

    Google Scholar 

  39. WHO/UNICEF/IVACG Task Force. Vitamin A Supplements: A guide to their use in the treatment and prevention of vitamin A deficiency and Xerophthalmia. Geneva: WHO 1988.

    Google Scholar 

  40. WHO. WHO Expert Committee on onchocerciasis, Third Report. Geneva: WHO Technical Report Series 752; 1987: 1–167.

    Google Scholar 

  41. Buck AA. Onchocerciasis: Symptomatology, pathology, diagnosis. Geneva: WHO 1974.

    Google Scholar 

  42. Taylor HR. Onchocerciasis. Int Ophthalmol 1990; 14: 189–194.

    Google Scholar 

  43. Thylefors B. Onchocerciasis: An overview. Int Ophthalmol Clin 1990; 30(1): 21–2.

    Google Scholar 

  44. Aziz MA, Samba, Diallo, et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982; ii: 171–3.

    Google Scholar 

  45. Dadzie KY, Remme J, Alley ES, et al. Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus. Trans R Soc Trop Med Hyg 1990; 84(1): 103–8.

    Google Scholar 

  46. Pacque MC, Dukuly Z, Greene BM, et al. Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions. Bull WHO 1989; 67(6): 721–30.

    Google Scholar 

  47. Taylor HR, Murphy RP, Newlands HS, et al. Comparison of the treatment of ocular onchocerciasis with ivermectin and diethylcarbamazine. Arch Ophthalmol 1986; 104: 863–70.

    Google Scholar 

  48. Remme JFH. The epidemiology and control of onchocerciasis in West Africa. Rotterdam (The Netherlands), 1989. Thesis.

  49. Lelij A van der, Doekes G, Hwan BS, et al. Humoral autoimmune response against S-antigen and IRBP in ocular onchocerciasis. Invest Ophthalmol Vis Sci 1990; 31(7): 1374–80.

    Google Scholar 

  50. Ngu JL, Tume C, Lando G, et al. Comparative studies of clinical groups of patients in an onchocerciasis endemic area for evidence of immune-mediated protection. Trop Med Parasitol 1989; 40(4): 460–3.

    Google Scholar 

  51. Wandji K, Cesbron JY, Dissous C, et al. Use of monoclonal antibodies for the characterization of Onchocerca volvulus antigens. Trop Med parasitol 1990; 41(1): 13–9.

    Google Scholar 

  52. Lelij A van der, Immununological and therapeutical aspects of ocular onchocerciasis. Amsterdam (The Netherlands), 1991. Thesis.

  53. Rothova A, Lelij A van der, Stilma JS, et al. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. Am J Ophthalmol 1990; 15, 110(1): 6–16.

    Google Scholar 

  54. Bird AC, Anderson J, Fuglsang H. Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol 1976; 60: 2–20.

    Google Scholar 

  55. WHO. WHO Expert Committee on Leprosy, Sixth Report. Geneva: WHO Techical Report series 768, 1988.

  56. WHO. A guide to leprosy control, 2nd ed. Geneva: WHO, 1988.

    Google Scholar 

  57. Courtright P, Johnson G. Prevention of blindness in leprosy. London: International Centre for Eyehealth, 1988.

    Google Scholar 

  58. Carmichael TR, Wolpert M, Koornhof HJ. Corneal ulceration at urban African hospital. Br J Ophthalmol 1985; 69: 920–926.

    Google Scholar 

  59. Foster A, Sommer A. Childhood blindness from corneal ulceration in Africa: causes, prevention, and treatment. Bull WHO 1986; 64(5): 619–23.

    Google Scholar 

  60. Upadhyay MP, Rai NC, Brandt F, et al. Corneal ulcer in Nepal. Graefe's Arch Clin Exp Ophthalmol 1982; 219: 55–59.

    Google Scholar 

  61. Upadhyay MP, Gurung BJ, Shrestha BR, et al. Ocular trauma: An epidemiological profile. J Inst Med 1983; 4: 145–156.

    Google Scholar 

  62. Gugnani HC, Talwas RS, Njoku-obi A, et al. Mycotic keratitis in Nigeria. Br J Ophthalmol 1976; 60: 607–613.

    Google Scholar 

  63. Puttanna ST. Mycotic infections of the cornea. All Indian Ophthalmol Soc 1976; 15: 11–18.

    Google Scholar 

  64. Srivastava OP, Koul RL, Gupta SP. A survey of fungi from eye patients in Lucknow. Indian J Ophthalmol 1976; 24: 19–21.

    Google Scholar 

  65. Christy NE. High volume efficient cataract surgery in developing countries. Int Ophthalmol 1990; 14: 141–146.

    Google Scholar 

  66. Minassian DC, Mehra V. 3,8 million blinded by cataract each year: Projections from the first epidemiological study of incidence of cataract blindness in India. Br J Ophthalmol 1990; 74(6): 341–344.

    Google Scholar 

  67. Young PW, Schwab L. Intra-ocular lens implantation in developing countries; an ophthalmic surgical dilemma. Ophthalmic Surgery 1989; 20: 241–4.

    Google Scholar 

  68. Ellis-Jones DW. Trachomatous entropion: A simple operation for its treatment. Tropical Doctor 1972; 2: 24–29.

    Google Scholar 

  69. GLT. The glaucoma laser trial (GLT) 2: Results of Argon laser trabeculoplasty versus topical medicines. Ophthalmol 1990; 97(11): 1403–1413.

    Google Scholar 

  70. Wood ML. Trabeculectomy in Kikuyu Eye Unit. East African J Ophthalmol 1988; 8: 5–7.

    Google Scholar 

  71. Berson D, Zauberman H, Landau L, et al. Filtering operations in Africans. Am J Ophthalmol 1969; 67: 395–398.

    Google Scholar 

  72. Cassady JR. Results of iridencleisis in Negro and White Races. Arch Opthalmol 1959; 62: 239–241.

    Google Scholar 

  73. Chatterjee S, Ansari MW. Microsurgical trabeculetomy in Ghana. Br J Ophthalmol 1972; 56: 783–787.

    Google Scholar 

  74. Monteiro de Gandt D, Maertens K. Resultats d'une enquête sur le glaucome chronique simple des sujets de race noire an republique de Zaire. Ann Oculist (Paris) 1973; 206: 393–399.

    Google Scholar 

  75. Védy J. Premiers résultats de la trabeculotomie ab externo chez le noir au Tchad. Medicine Tropicale 1972; 32: 446–452.

    Google Scholar 

  76. Welsh NH. Failure of filtration operations in the African. Br J Ophthalmol 1970; 54: 594–598.

    Google Scholar 

  77. Sommer A, Tarwotjo I, Hussaini G, et al. Increased mortality in mild vitamin A deficiency. Lancet 1983; ii: 585–8.

    Google Scholar 

  78. Rahmathullah L, Underwood BA, Thulasiraj RD, et al. Reduced mortality among children in Southern India receiving a small weekly dose of vitamin A. N Eng J Med 1990; 323(14): 985–987.

    Google Scholar 

  79. Mectizan Expert Committee. Instructions and guidelines. Atlanta, 1988.

  80. Rothova A, Lelij A van der, Stilma JS, et al. Side effects of ivermectin in treatment of onchocerciasis. Lancet 1989; i: 1439–14.

    Google Scholar 

  81. Stilma JS, Rothova A, Lelij A van der, et al. Ocular and systemic side effects following Ivermectin treatment in onchocerciasis patients form Sierra Leone. Acta Leidensia 1990; 59(1–2): 207–210.

    Google Scholar 

  82. Sole G de, Remme JFH, Awadzi K, et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull WHO 1989; 67(6): 707–19.

    Google Scholar 

  83. Johnson GJ, Foster A. Training in community ophthalmology. Int Ophthalmol 1990; 14(3): 211–226.

    Google Scholar 

  84. Stilma JS, Bridger S. Causes and prevalence of blindness in the Northern Province of Sierra Leone. Doc. Ophthalmol 1983; (56): 115–122.

    Google Scholar 

  85. WHO. Strategies for the prevention of blindness in national programmes: A primary health care approach. Geneva: WHO, 1984.

    Google Scholar 

  86. Sutter E, Foster A, Francis V. Hanyane: A village struggles for eye-health. MacMillan Publishers, 1989.

  87. Schwab L. Primary eye care in developing nations. Oxford: University Press, 1987.

    Google Scholar 

  88. Sandford-Smith J. Eye diseases in hot climates, 2nd ed. London: Wright Publishers, 1990.

    Google Scholar 

  89. King M. Health is a sustainable state. Lancet 1990; 336: 664–667.

    Google Scholar 

  90. Kara Jose N, Contreras F, Campos MA, et al. Screening and surgical intervention results form cataract-free-zone projects in Campinas, Brazil and Chimbote, Peru. Int Ophthalmol 1990; 14: 155–164.

    Google Scholar 

  91. Thylefors B. The World Health Organization's programme for the prevention of blindness. Int Ophthalmol 1990; 14(3): 211–19.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. F.C. Dondersinstitute, P.O. Box 85500, 3508, GA Utrecht, The Netherlands

    J. S. Stilma, S. Franken, M. Hogeweg & P. Hardus

Authors
  1. J. S. Stilma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Franken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Hogeweg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Hardus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stilma, J.S., Franken, S., Hogeweg, M. et al. Points of action in the campaign against blindness in developing countries. Doc Ophthalmol 78, 285–305 (1991). https://doi.org/10.1007/BF00165693

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165693

Key words

Search

Navigation